NCT03978078Recruiting
A Clinicobiological Database in Metastatic Digestive Cancers
Development of a Prospective Clinicobiological Database in Metastatic Digestive Cancers
Source: ClinicalTrials.gov · Last updated 12 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Creation of a collection of blood samples that will be collected before and then under treatment in patients with digestive adenocarcinoma during the 1st and 2nd metastatic line and which, depending on scientific progress, can be used for research projects aimed at developing tailored patient management strategies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 5 Jun 2019
- Start date
- 12 Sept 2016
- Primary completion date
- Sept 2026
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- NCT number
- NCT03978078
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 12 Sept 2016 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient already undergoing specific treatment (chemotherapy and/or targeted therapy) in 1st or 2nd metastatic line
Age
- Male or female \< 18 years old
Other
- Non-adenocarcinoma histological type
- Pregnant and/or breastfeeding woman
- Patient not affiliated to a social security system
- Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons
- Patient who is included in a Phase I-II therapeutic trial modifying usual management and involving additional and specific blood samples
Who the study is looking for
- Male or female ≥ 18 years old
- Histological documentation of adenocarcinoma of the colon or rectum, small intestine, pancreas, stomach, bile duct, oesophagus
- Patient who will receive a first or second line metastatic chemotherapy and/or targeted therapy
- Informed consent form (ICF) signed
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Regional Du Cancer de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.